Is interventional cardiology largely sorted out? Can we further improve results of currently available percutaneous revascularisation techniques and devices? More poignantly, in this time of economic hardship, can we afford further developments?1,2
Science and technology are moving forward, and most likely for the better. Recent innovations in bioabsorbable endoprostheses will surely have a major impact on the management of patients with coronary artery disease, when their high price will have been decreased or will have been proved worthwhile.3 Moreover, ultra-deliverable stents have been developed4 with crossing profiles as small as 0.014”.5 Finally, the combination of antirestenotic and pro-healing effects will ...
200 Issues at the Heart of Interventional Cardiology
January 28, 2022